← ANALYST RATINGS · TIPRANKS
Iradimed (IRMD): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy1 Hold0 Sell
Ratings of 2 analysts in the last 3 months12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $120, the highest $120, the lowest $120. The average is +35.9% from the last price of $88.27.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $91.00 | Buy | +3.1% | Reiterated | 23.09.26on TipRanks 00:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $89.00 | Hold | +0.8% | Reiterated | 23.09.26on TipRanks 00:06 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $91.00 → $92.00+1.1% | Buy | +4.2% | Reiterated | 23.09.26on TipRanks 00:06 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $87.00 | Hold | −1.4% | Reiterated | 23.09.26on TipRanks 00:06 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $92.00 | Buy | +4.2% | Reiterated | 23.09.26on TipRanks 00:06 | — | |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | — | Hold | — | Initiated | 22.09.26on TipRanks 06:50 | +4.9%next day +0.5% · 5 days +1.1% | ↗ |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $106 → $99.00−6.6% | Buy | +12.2% | Reiterated | 20.08.26on TipRanks 00:06 | — | |
| Frank Takkinen★★★★★★★★★★#11823 · hits 38% · avg −3.6% | Lake Street | $120 | Buy | +35.9% | Reiterated | 03.08.26on TipRanks 09:10 | −0.7%next day −0.1% · 5 days −3.4% | ↗ |
| Ilya Zubkov★★★★★★★★★★#5009 · hits 59% · avg +9.5% | Freedom Capital Markets | $116 | Buy | +31.4% | Initiated | 02.04.26on TipRanks 10:35 | −0.4%next day −1.1% · 5 days −6.5% | ↗ |
| Kyle Bauser★★★★★★★★★★#12304 · hits 37% · avg −14.9% | Roth MKM | $98.00 → $120+22.4% | Buy | +35.9% | Reiterated | 11.02.26on TipRanks Feb 10 15:45 | +9.8%next day −1.9% · 5 days −2.7% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Iradimed
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $120 at a price of $86.22 (+39.2%); now: $120 at $88.27 (+35.9%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.55 (from $0.54 to $0.56). Last quarter: $0.46.
Sales
Next quarter’s sales estimate — $23M (from $23M to $24M). Last quarter: $20M.
Best top-analyst consensus in the sector · Healthcare
About Iradimed
- CEO: Roger E. Susi
- Employees: 166
- 1025 Willa Springs Drive, Orlando, FL, 32826, US
- www.iradimed.com
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Data from the stock’s TipRanks forecast page, read 93 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗